protein ubiquitination is a versatile protein modification that regulates virtually all cellular processes. this versatility originates from polyubiquitin chains, which can be linked in eight distinct ways. the combinatorial complexity of eight linkage types in homotypic (one chain type per polymer) and heterotypic (multiple linkage types per polymer) chains poses significant problems for biochemical analysis. Here we describe ubicrest, in which substrates (ubiquitinated proteins or polyubiquitin chains) are treated with a panel of linkage-specific deubiquitinating enzymes (DuBs) in parallel reactions, followed by gel-based analysis. ubicrest can be used to show that a protein is ubiquitinated, to identify which linkage type(s) are present on polyubiquitinated proteins and to assess the architecture of heterotypic polyubiquitin chains. DuBs used in ubicrest can be obtained commercially; however, we include details for generating a toolkit of purified DuBs and for profiling their linkage preferences in vitro. ubicrest is a qualitative method that yields insights into ubiquitin chain linkage types and architecture within hours, and it can be performed on western blotting quantities of endogenously ubiquitinated proteins. cleavage event at Arg74 of ubiquitin, and the resulting monoubiquitin remnants could, in theory, also be investigated for the presence of heterotypic chains.
IntroDuctIon
Protein ubiquitination is the attachment of the 76-aa protein ubiquitin to Lys residues in substrates 1 . Ubiquitination most commonly targets proteins for degradation, and it is estimated that the majority of cellular proteins are modified during their lifetime. However, ubiquitin also has many other roles in cells, including the activation of signaling cascades, the shuttling of proteins to and from membranes and the assembly of protein complexes, for example, at sites of DNA damage. In addition, ubiquitination regulates replication, transcription, splicing and translation of proteins. Many of these roles do not involve protein degradation, but they use the adapter functions of ubiquitin 2 .
The versatility of ubiquitin to perform such distinct functions is generated by its ability to assemble a large variety of signals. Proteins can be monoubiquitinated at one or multiple sites, but most importantly the ubiquitin molecule itself can be ubiquitinated at eight distinct positions 2, 3 . This gives rise to eight types of homotypic ubiquitin chains (which are chains that exclusively contain a single linkage type), and also to a mindboggling number of possibilities for heterotypic mixed and branched ubiquitin chains (also referred to as forked 4 or hybrid 5 chains). In heterotypic ubiquitin chains, a homotypic chain is either extended by a second chain type such that each ubiquitin still only has one Lys modified (mixed chains), or a ubiquitin molecule in the chain is modified at multiple positions (branched chains). Although some functions of heterotypic ubiquitin chains have emerged recently 5, 6 , their abundance, architectural diversity and importance are largely unclear 3 .
Existing methods for analyzing ubiquitin chains
Numerous methods have been developed to assess which ubiquitin chain types are present on substrates. Ubiquitin mutants in which one or several Lys residues are mutated to Arg have been instrumental in revealing the diversity of the ubiquitin signal 2, 7 .
These mutants can be used in vitro to understand the specificity of E3 ligase systems, or in vivo where they can be used in addition to endogenous ubiquitin or upon ubiquitin knockdown in ubiquitin replacement strategies 8 . However, mutation of ubiquitin can lead to changes in the affinity of binding partners, or to changes in polyubiquitin structure and/or dynamics 9 , with the effect that chains are no longer assembled or disassembled 10, 11 .
Linkage-specific antibodies that specifically recognize Lys11, Lys48, Lys63 or linear/Met1-linked chains have been developed and are excellent reagents to understand the involvement of these linkage types in different pathways [12] [13] [14] . Similar questions can be addressed with recently developed ubiquitin chain sensors based on linkage-specific ubiquitin-binding domains 15, 16 .
Advances in mass spectrometry (MS)-based methods to study ubiquitin sites in substrate proteins and to analyze the linkage types present in samples have revolutionized the field of ubiquitin chain research in recent years [17] [18] [19] [20] . These are usually bottom-up approaches in which proteins are trypsin-digested into peptides and then subjected to liquid chromatography-tandem MS for identification. Ubiquitination sites on substrates can be identified because trypsin cleavage results in a dipeptide (Gly-Gly) remnant with a monoisotopic mass of 114.043 Da on peptides that were ubiquitinated 21 . Absolute quantification techniques allow the assessment of the relative abundance of various ubiquitin linkages 17 , and enrichment techniques such as the development of antibodies against tryptic ubiquitination-site remnants allow the analysis of ubiquitination at a global proteomic scale 18, 20 . However, although these techniques can help identify particular ubiquitin linkage types on a substrate, they do not reveal details on chain architecture, which is difficult to assess using current technologies 22 . Xu and Peng 23 described a method of middle-down MS that allows the characterization of chain length and linkage. In this method, ubiquitin is partially trypsindigested in optimized native conditions, resulting in a single Deubiquitinase-based analysis of ubiquitin chain architecture using Ubiquitin Chain Restriction (UbiCRest) points in their life cycles. This was demonstrated elegantly by using Lys63-and Lys48-linkage-specific antibodies in a study of RIP1, a well-studied ubiquitin target in cytokine signaling 12 .
The apparent co-occurrence of 'signaling' chain types (Lys63 and Met1) and degradative (Lys48 and Lys11) chain types on proteins may simply reflect different pools of proteins at different stages of their life cycles.
Overview of UbiCRest: using DUBs to assess ubiquitin chain type and architecture
To design a qualitative and quick method to assess ubiquitin chain type and architecture, we exploited the intrinsic linkage specificity of DUBs. Advances in biochemistry and chemical biology have enabled a comprehensive profiling of DUB linkage preference and confirmed the specificity of, e.g., the Lys63-specific DUB AMSH, and of the Lys48-specific DUB OTUB1, which is now understood in molecular detail [25] [26] [27] . We have contributed specificity analysis of the human ovarian tumor (OTU) DUB family, and we have discovered that OTU enzymes have defined linkage preferences, identifying enzymes with relative specificity for each of the eight ubiquitin linkage types 28 (e.g., Fig. 1 ). This is interesting and requires further studies, as it suggests independent roles for each chain type in the regulation of cellular signaling processes.
In addition, we realized that the availability of linkage-specific DUBs enables their use as tools to address questions in ubiquitin chain research 28 (Fig. 2 and Table 1 ; find a generalized purification protocol in Box 1). Once the linkage specificity of each DUB at a given working concentration has been established ( Fig. 1 and Box 2), a panel of DUBs with complementary specificity can be used to treat polyubiquitin or polyubiquitinated samples (Fig. 2) to assess (i) the types of ubiquitin linkages present in the sample (Fig. 3) , and (ii) the architecture of linkages within the chains (Fig. 4) . These can be either generated in vitro by using a defined ubiquitin chain assembly system or by immunoprecipitating a ubiquitinated protein of interest from the cell lysate. The color of the circles representing ubiquitin moieties indicates the Lys residue it is attached to. Substrate-bound and free ubiquitin is shown in white.
Overview of the procedure
The starting point for UbiCRest is faithfully reproducible ubiquitinated protein that can be visualized by a PAGE-based method. Fig. 2a) . Variables that can be adjusted are incubation time, temperature and DUB concentration. We usually perform short assays (15-30 min) at low and high DUB concentrations, whereby signs of activity at low concentrations indicate the presence of the tested chain type, whereas at a higher concentration cleavage of the preferred linkage is complete and may indicate whether other chains are still on the substrate (Fig. 3a,d) . Alternatively, longer incubation times can be beneficial to test the completeness of the reaction. To reveal the sometimes small changes in polyubiquitination by DUB treatment, it is important that all samples have equal amounts of protein, and that they are run on a single gel side-by-side. This often limits the number of time points or DUB concentrations that can be used in a single assay (Fig. 3a,d ).
Advantages and applications of UbiCRest
UbiCRest analysis allows for quick and easy identification of protein ubiquitination (as opposed to, e.g., SUMOylation), the linkage types present in polyubiquitinated substrates, and the chain architecture of heterotypic chains. The advantages of UbiCRest are an easy setup that does not require special equipment and the speed of the assay, which takes merely hours to run once DUBs are available (depending on the method of detection). With UbiCRest, most linkage types can be distinguished, but the assay is particularly useful for the detection of Lys11, Lys48, Lys63 and Met1-linked chains, as highly specific DUBs are available for these chain types. Similarly specific DUBs for the remaining chain types are unknown to date, but would be highly beneficial for this purpose. So far, only a subset of DUBs have shown preference for different ubiquitin linkage types 28 . We expect that in some cases the activity or specificity of the used DUBs could be enhanced by mutations or fusion to binding partners. For example, an OTUB1-E2 fusion protein should enhance the activity of this enzyme 27, 30 . In addition, it is possible that nonhuman OTU DUBs have distinct linkage preferences and have evolved missing activities of, e.g., a Met1/linear OTULIN Any (10 nM to 10 µM) Very active and specific; can be used at high concentrations Lys6-specific DUB. Hence, it is always worthwhile to test the linkage specificity of unstudied enzymes. Moreover, although most members of the USP family show broad specificity 31 (and are substrate-rather than linkage-targeted DUBs), linkage-specific members of this DUB family may well exist. One example is the ubiquitin-specific protease CYLD, which prefers Lys63 and Met1 linkages over Lys48-linked chains 24 .
It is worthwhile noting that linkage-specific DUBs may have many applications beyond UbiCRest, such as in ubiquitin proteomics and global ubiquitin linkage profiling. In addition, for the identification of ubiquitination sites on proteins, it may be beneficial to decrease the complexity of the modification. This could be achieved by using DUBs to remove ubiquitin chains from the substrate in such a way that only the last attached, proximal ubiquitin on the substrate is preserved. Moreover, inactivation of linkage-specific enzymes by mutation of the catalytic Cys can generate high-affinity, linkage-specific ubiquitin-binding domains that could be used in other methods, e.g., as ubiquitin chain sensors. These potential applications would help address many current questions and problems in ubiquitin research.
Limitations of UbiCRest
As with any biochemical method, there are a number of caveats that must be considered when using UbiCRest. First, several of the enzymes may become nonspecific, and they might target ubiquitin chain types other than the expected ones when used at high concentrations. Exceptions to this are the highly specific DUBs OTULIN, OTUB1 and AMSH, which can be used at very high concentrations without showing signs of cross-specificity 32, 33 (Fig. 3a,d) . DUB specificity has so far only been comprehensively tested against diubiquitin, and it may be different for longer chains. A good example of difference in specificity against diubiquitin versus longer chains is OTUD2, a DUB which contains an additional ubiquitin-binding site that targets the enzyme to longer Lys11-linked ubiquitin chains 28 . These issues are exacerbated by the fact that it is often difficult to estimate the amount of substrate and the length of individual ubiquitin chains on the substrate, e.g., for material from immunoprecipitations.
Another issue that we have observed repeatedly relates to immunoprecipitations and the amount of substrate on beads. Usually, one would minimize the bead volume to increase the
Box 1 | Expression and purification of DUBs • tIMInG 4-14 d
concentration of polyubiquitinated material. We have found that the concentration of ubiquitinated protein on beads (e.g., in an immunoprecipitate) can be too high, and we suspect that ubiquitin forms partly unfolded aggregates or superstructures that become uncleavable. Boiling of samples can also result in uncleavable material, and other harsh conditions during the isolation of the protein may also lead to material that is inert to DUB treatment. This can be overcome by careful handling of polyubiquitinated samples and by reducing the amount of polyubiquitinated protein on beads.
Even when kept intact, ubiquitin chain structures may pose problems for DUB cleavage 11, 29 . Morgan and colleagues 11 elegantly showed that many DUBs were unable or severely impaired to hydrolyze long (n > 4) Lys48-linked chains, which may well be owing to the compact structures adopted by these polymers.
What is not clear at this stage is whether the DUBs used are equally active against complex heterotypic (mixed or branched) polyubiquitin chains compared with homotypic chains. It is conceivable that more complicated branched structures pose a substantial problem for DUBs that have to recognize two ubiquitin molecules in a linkage-specific manner. However, so far, marked differences could not be detected when heterotypic Lys6/Lys48, Met1/Lys63 and Lys48/Lys63 polymers were analyzed 5, 32, 34 . Taken together, although false-positive results may arise from enzyme cross-specificity, negative results from UbiCRest analysis may be due to reasons other than the absence of particular chain linkages in the substrates. It is highly advisable to use UbiCRest in conjunction with complementary, orthogonal techniques such as MS or the use of ubiquitin mutants. However, owing to the speed and sensitivity of UbiCRest, our method may be a good starting point for ubiquitin chain type analysis.
Experimental design
Deubiquitinases. Linkage-specific DUBs are able to hydrolyze specific ubiquitin chain types on substrates, making them useful biochemical reagents. DUBs from the OTU and JAMM (JAB1/MPN/Mov34 metalloenzyme) family can be expressed in Escherichia coli and can be purified with few chromatographic steps to high purity. In most cases, expression as a cleavable glutathione-S transferase (GST) fusion enables the generation of milligram quantities (see protocol in Box 1). Alternatively, most DUBs are now available from commercial sources, and a UbiCRest kit can be purchased that contains the key enzymes for the experiments detailed below. Table 1 lists the DUBs used in UbiCRest.
We have found that the activity of individual DUBs varies greatly 28 . Although some are highly active (OTULIN, vOTU (viral OTU), USP21, OTUD1 and Cezanne) and should be used at low concentrations, others require substantially higher concentrations to show activity (OTUB1 and OTUD2; Table 1 ). Box 2 outlines an assay for determining the linkage specificity of DUBs over a range of concentrations in order to determine the optimal working concentration of each DUB for UbiCRest analysis. OTU DUBs are Cys proteases, and they are prone to (reversible) oxidation of their catalytic residue 35 , which needs attention during their purification.
Box 2 | Qualitative in vitro DUB assay • tIMInG ~4 h
The linkage specificity of DUBs can be limited to certain chain types, and this may vary with DUB family. It is advised to characterize the linkage specificity for each DUB when purified for the first time. In addition to establishing linkage specificity, the assay also reveals the concentrations at which the particular DUB batch should be used. It may not be necessary to repeat the entire DUB specificity panel for highly specific DUBs for each purification; however, for less-specific DUBs, batch-to-batch variation in activity may affect the working concentration. procedure 1. Prepare 2× concentrated ubiquitin stocks for all eight diubiquitin substrates containing 10 µM ubiquitin in DUB reaction buffer (5 µM final concentration in reactions). Diubiquitin concentrations should be frequently re-adjusted to ensure uniform staining results. 2. Dilute DUBs (prepared as described in Box 1 or obtained from commercial sources) in DUB dilution buffer to 2× final concentrations (table 1) and preincubate at room temperature for 10-15 min.  crItIcal step Preincubation of enzymes with catalytic Cys residues in a high-DTT buffer (here: DUB dilution buffer) is often required to achieve full activity through reduction of oxidized species. 3. Start the reaction by mixing 10 µl of each of the diubiquitin solutions (from step 1) and enzyme stock (from step 2), and incubate the reaction mixture at 37 °C. 4. Remove 5-µl aliquots at required time points and immediately mix them with 5 µl of 4× LDS sample buffer to stop the reaction. We suggest a time course of 0, 5 and 30 min. If required, adjust the DUB concentration in subsequent runs in order to observe incomplete cleavage of the preferred substrate after 5 min and, ideally, complete hydrolysis after 30 min. For the '0 min' time point, mix 2.5 µl of both the substrate and the DUB solution directly in 4× LDS sample buffer one after the other.  pause poInt Once samples are mixed with LDS sample buffer, they can be stored at −20 °C for up to 1 year and analyzed by SDS-PAGE at a later time. 5. Resolve samples by SDS-PAGE on 4-12% (wt/vol) gradient gels run with MES buffer (Fig. 1) .  crItIcal step Do not boil samples containing ubiquitin chains, as this may cause degradation and smearing of bands on SDS-PAGE gels. ? trouBlesHootInG 6. Perform silver staining, e.g., by using the Silver Stain Plus kit (Bio-Rad) according to the manufacturer's instructions. Stop the staining reaction as soon as a satisfactory level of staining has been achieved.  crItIcal step Untimely stopping results in uneven staining or a strong background.
Samples. Polyubiquitin is the substrate for UbiCRest analysis.
In vitro-assembled and in vitro-purified polyubiquitin of unknown composition and architecture, generated, e.g., by an uncharacterized E2 or E3 ligase, can be examined using UbiCRest regardless of whether the polyubiquitin is unattached (described in Step 1A, 'assembly A' of the PROCEDURE, using the example of NleL-assembled chains), attached to the ligase (autoubiquitination, described in Step 1A, 'assembly B' of the PROCEDURE, using E3 ubiquitin-protein ligase NEDD4 (NEDD4) as an example) or attached to a substrate. In vivoubiquitinated substrates can be examined by UbiCRest for linkage composition and architecture when polyubiquitin can be faithfully and reproducibly detected (as described in Step 1B of the PROCEDURE, using the example of RIP1); in these applications, western blotting against proteins or tags is essential owing to the high background of ubiquitinated proteins in cells (see 'Visualizing the sample'). In addition to the experimental samples, purified ubiquitin chains of defined linkage composition C o n t r o l U S P 2 1
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) C e z a n n e are important to establish DUB preference and working concentration using the assay described in Box 2; these substrates can be obtained commercially.
Visualizing the sample. Perhaps the most important prerequisite for this protocol is that polyubiquitin or a polyubiquitinated protein can be faithfully visualized. This can be achieved as follows:
Silver, SyPro or Coomassie staining. If large amounts of protein are available (e.g., from in vitro reactions) samples can be separated by SDS-PAGE and visualized by standard silver or Coomassie staining protocols. If a polyubiquitin smear is visible, this is ideal for UbiCRest, and it generates the highest amount of information. We have found that Coomassie staining often leads to poor staining of polyubiquitin, in contrast to silver staining, which seems to visualize the high-molecular-weight polyubiquitin much better (e.g., Fig. 3a) .
Western blotting against ubiquitin. This method uses either ubiquitin-specific antibodies, which examine the entire ubiquitin content of the sample, or when a tagged ubiquitin (such as FLAG-ubiquitin, hemagglutinin (HA)-ubiquitin etc.) is used, an antibody specific to the tag. Standard protocols for visualizing a • • polyubiquitinated protein in a cell lysate usually include an initial immunoprecipitation step to enrich the protein of interest in its modified and unmodified forms, and the ubiquitinated forms are then visualized by detecting the ubiquitin. UbiCRest can be used on immunoprecipitated material while still immobilized. Western blotting using linkage-specific antibodies. Linkage-specific antibodies are available for four of the eight linkage types [12] [13] [14] , and they can be used to visualize individual chain types in samples and to investigate their disappearance with UbiCRest.
Western blotting against the protein of interest. This method is the most direct way to test which chain types are present on a protein of interest. In some cases, antibodies directed against a protein of interest can visualize the modified forms of the protein; this depends on the quality of the antibody and on the fraction of protein that is modified. A good example is RIP1, which shows strong polyubiquitination after, e.g., tumor necrosis factor-α (TNF-α) stimulation of cells 12 (Fig. 3d) , and MyD88 and IRAK, which are ubiquitinated after interleukin (IL)-1 treatment 5 .
In essence, researchers who are able to visualize polyubiquitinated proteins by whatever means necessary should be able to perform UbiCRest on such samples. As the question about the ubiquitin chain type usually arises from having seen the modified form of the protein, this step is usually already established. We have found that the visualization protocols for polyubiquitin detection vary greatly from project to project and from lab to lab, and they have often undergone substantial optimization-hence, every visualization protocol is different. Nonetheless, the UbiCRest protocol described here should be useful for most cases.
Controls.
UbiCRest is intrinsically controlled, as numerous DUBs are used to treat a polyubiquitinated sample. Most important is the establishment of a positive control, whereby USP21 or another nonspecific DUB should remove all of the polyubiquitin in the reaction. An untreated and a USP21-treated sample establish the window in which differences can be detected. In some cases, it can be beneficial to include a catalytically inactive or inactivated DUB as a control. Met1-linked ubiquitin chains can be attached to pre-existing Lys63-linked chains, and they may account for only a small fraction of the entire polyubiquitin content 5 . In the case of UbiCRest on RIP2, running reactions with OTULIN and inactive OTULIN side by side revealed clear differences, showing that high-molecular weight ubiquitin chains on RIP2 contained Met1-linkages 36 . The easiest way to inactivate DUBs is to boil the enzymes for 5 min before using them in UbiCRest.
• • 2 O to 500 ml. Store this buffer in aliquots of 1 ml at −20 °C for at least 1 year. 10× DUB reaction buffer 10× DUB reaction buffer is 500 mM Tris (pH 7.5), 500 mM NaCl and 50 mM DTT. For 100 ml, dissolve 6.1 g of Trizma base, 2.9 g of NaCl and 0.77 g of DTT in ddH 2 O; adjust pH with HCl to 7.5 and add ddH 2 O to 100 ml. This buffer can be stored in small aliquots of 0.5 ml at −20 °C for at least 1 year. 20× ubiquitin ligation buffer 20× ubiquitin ligation buffer is 800 mM Tris (pH 7.5), 200 mM MgCl 2 and 12 mM DTT. For 100 ml, dissolve 9.7 g of Trizma base, 1.2 g of NaCl and 0.19 g of DTT in ddH 2 O; adjust the pH with HCl to 7.5 and add ddH 2 O to 100 ml. This buffer can be stored in small aliquots of 0.5 ml at −20 °C for at least 1 year. Immunoprecipitation (IP) lysis buffer For immunoprecipitation of in vivo substrates, prepare IP lysis buffer containing 20 mM Tris (pH 7.4), 150 mM NaCl, 2.5 mM EDTA, 1% (vol/vol) Triton X-100, EDTA-free complete protease inhibitor, 100 mM NaF, 5 mM N-ethylmaleimide and 10 mM iodoacetamide. This buffer should be freshly prepared. IP wash buffer For immunoprecipitation of in vivo substrates, prepare IP wash buffer containing 20 mM Tris (pH 7.4), 150 mM NaCl, 2.5 mM EDTA, 1% (vol/vol) Triton X-100 and EDTA free complete protease inhibitor. This buffer should be freshly prepared.
•
Generation of substrates for ubicrest • tIMInG 1-6 d 1| Substrates for UbiCRest analysis can be generated in a number of ways (see 'Experimental design' section). Here we provide details for in vitro generation of polyubiquitin (Step 1A) and immunoprecipitation of polyubiquitinated protein from cell lysate (Step 1B). In
Step 1A, we provide details for generating the model substrates used in Figures 3a and 4b .
In Step 1B, we use immunoprecipitation of the TNF receptor complex (TNF-RSC) as an example, the UbiCRest analysis of which is shown in Figure 3d .  crItIcal step Any appropriate in vitro assembly system can be used to generate substrates for UbiCRest analysis. Established assembly systems with known ubiquitin chain composition can serve as positive controls. (ii) Stop the reaction by adding 2 mU of Apyrase. Check the quality of the assembled substrate on a 4-12% (wt/vol) SDS-PAGE gradient gel.
? trouBlesHootInG  pause poInt Samples can be flash-frozen and stored at −80 °C for at least 1 year. (iii) (Optional) If substantial amounts of monoubiquitin remain in the assembly reaction (assembly A) or a specific length of polyubiquitin chains is required (assembly B), a subsequent purification of the substrate is recommended to enable clearer visualization of subsequent UbiCRest analysis. Subject the sample to size-exclusion chromatography using GST buffer 1 (assembly A: Superdex 75 PC 3.2/30 on an ÄKTA Micro system; assembly B: HiLoad 16/60 Superdex 75 on an ÄKTA Explorer system (GE Healthcare)). Collect peak fractions and confirm the quality on a 4-12% (wt/vol) SDS-PAGE gradient gel.  pause poInt Samples can be flash-frozen and stored at −80 °C for at least 1 year. (B) Immunoprecipitation of ubiquitinated substrates for ubicrest analysis • tIMInG ~6 d  crItIcal step This option describes how to generate and detect an in vivo ubiquitinated protein, using RIP1 as an example. Cell lines, cell culture techniques, stimulations, detection methods, affinity tags, antibodies and so on will vary for other proteins under investigation. The key aim is to obtain a sample that generates a detectable polyubiquitin smear in western blot analysis and that is compatible with DUB cleavage.
Step 1B(ix-xi) needs to be optimized for each different substrate in subsequent UbiCRest analysis. (viii) To the clarified lysate, add 200 µl of anti-FLAG M2 affinity gel (40 µl per 15-cm dish), which was equilibrated by washing and centrifuging three times in IP lysis buffer, and then incubate the mixture on a rotating wheel at 4 °C overnight. (ix) The following day, wash the beads five times. Each wash is done by centrifuging the beads at 1,000g for 3 min, removing the supernatant and adding 1 ml of IP wash buffer at 4 °C. Resuspend the beads in DUB dilution buffer in the final (fifth) step.  crItIcal step The volume of the final sample in DUB dilution buffer depends both on how many DUB incubations need to be carried out and the concentration of the polyubiquitinated substrate present after the immunoprecipitation. If the substrate concentration is too low, the amount of starting cells can be increased. If the substrate concentration is too high, the sample can be further diluted using DUB dilution buffer. Whether the substrate concentration is appropriate can only be judged by performing the UbiCRest analysis and analyzing the reactions by western blotting. (x) Transfer beads into separate tubes for subsequent DUB incubations. For the analysis of polyubiquitinated RIP1 (Fig. 3d) , 10 µl of beads were aliquotted per reaction. (xi) Analyze the experiment by western blotting using an antibody specific to the substrate protein under investigation;
we used a RIP1-specific antibody (Fig. 3d) .
? trouBlesHootInG ubicrest analysis • tIMInG 5-18 h 2| Prepare 2× and/or 5× concentrated DUB stocks (depending on the reaction setup; see Step 3 below) on ice by diluting enzymes using DUB dilution buffer, and preincubate them at room temperature (22 °C) for 10-15 min. Note that OTUD3, Cezanne, OTUD2, TRABID and OTUD1 are used at two different final enzyme concentrations (table 1) .  crItIcal step Preincubation of enzymes with catalytic Cys residues in a high-DTT (here, DUB dilution buffer) buffer is often required to achieve full activity through reduction of oxidized species.
3|
Depending on the substrate and the aim of the experiment, set up the UbiCRest reaction as follows: to determine ubiquitin chain composition of in vitro-assembled polyubiquitin (from Step 1A), set up reaction A (Fig. 3a) ; to determine ubiquitin chain composition of immunoprecipitated polyubiquitinated protein (from Step 1B), set up reaction B (Fig. 3d) ; and to analyze ubiquitin chain architecture of in vitro-assembled heterotypic polyubiquitin (from Step 1A), set up reaction C (Fig. 4b) . For each UbiCRest experiment, the number and type of DUBs can be tuned to the given scientific question.  crItIcal step Reaction volumes depend on the experimental setup and number of time points. Amount of input substrate depends on the minimal amount from which the polyubiquitin content can be faithfully and conveniently visualized. 5| Load 1-10 µl of each sample on SDS-PAGE gels and visualize the protein by silver staining or western blotting using standard methods.  crItIcal step Do not boil the samples containing ubiquitin chains, as this may cause degradation and smearing of bands on SDS-PAGE gels.  crItIcal step The use of MES-versus MOPS-SDS-PAGE running buffer determines how well monoubiquitin and short ubiquitin chains can be visualized as compared with polyubiquitinated proteins. Figure 3a was performed using MES running buffer, whereas in Figure 3d MOPS buffer was used.
? trouBlesHootInG 6| If required, repeat UbiCRest analysis (Steps 2-5) using different enzyme and/or substrate concentrations. In addition, the time course can be changed, e.g., by including more points for analysis.
? trouBlesHootInG Troubleshooting advice can be found in table 3. 
Interpreting the results
UbiCRest analysis can reveal a lot of information, depending on the subsequent detection of the reaction products. For example, in Figure 3a , autoubiquitinated NEDD4 was purified and treated, in solution, with the indicated DUBs. The resulting reaction mixture was then directly loaded onto an SDS-PAGE 4-12% (wt/vol) gradient gel, and bands were visualized by silver staining. The disappearance of the polyubiquitin smear is the key result, as this indicates that the given DUB has worked on the substrate and that the linkage in question is present (Fig. 3a) . It is equally interesting to visualize the small-molecular-weight reaction products, and to see whether monoubiquitin has been generated exclusively. This would provide evidence for chains of one chain type exclusively, or it would indicate whether short chains have been released (Figs. 3a and 4b) . The latter could indicate mixed or branched heterotypic polyubiquitination (Fig. 4) . The distinct running behavior of differentially linked free ubiquitin chains often allows an identification of released small chains (Fig. 3b,c) .
In some cases, OTU DUBs are unable to remove the last, proximal ubiquitin of a chain, which remains on the substrate, leading to defined bands with a molecular weight higher than the unmodified substrate. This shift of the substrate can indicate how many ubiquitination sites are present on particular proteins, and targeted MS/MS analysis of such bands may allow identification of the modified site(s). In Figure 3d , a variation of UbiCRest is shown, in which an endogenously modified protein, RIP1, is purified by TNF-receptor immunoprecipitation and subjected to UbiCRest. The purified TNF-RSC consists of a large number of proteins, many of which are ubiquitinated; this renders silver staining or detection by anti-ubiquitin less useful. Fortunately, the available antibody for RIP1 reveals modified forms of the protein (Fig. 3d) . High concentration of OTUD1 reduces the smear as compared with the control, suggesting the presence of Lys63-linked chains. OTUD2 also reduces the smear; however, this enzyme often releases intact chains, which cannot be visualized by western blotting against RIP1. Further examples of UbiCRest can be found in the literature 5, 28, 36, 37 .
characterization of mixed linkage chains
Branched ubiquitin chains represent a new frontier in ubiquitin research, and their abundance, function and relevance is currently unclear. We had shown that the bacterial effector E3 ligase NleL 32 assembles free ubiquitin chains with Lys6 and Lys48 linkages, giving rise to a large number of individual species 38 (Fig. 4a) . We used UbiCRest to show that both the linkages can occur in the same polymer (Fig. 4b) . For this, pentaubiquitin and hexaubiquitin were assembled using NleL and wild-type ubiquitin. The purified heterotypic sample was incubated with DUBs in four parallel reactions; OTUB1 (Lys48-specific), OTUD3 (prefers Lys6 over Lys48 chains), a mixture of OTUB1 and OTUD3, and vOTU (cleaves all isopeptide linkages). Samples were taken over a 90-min time course, and they were analyzed on a silver-stained SDS-PAGE gel. The complete hydrolysis of purified pentaubiquitin and hexaubiquitin to monoubiquitin by vOTU or the combination of OTUD3 and OTUB1 indicates that these enzymes can cleave all the linkages present in these heterotypic ubiquitin chains (Fig. 4b) . When the sample was treated with OTUB1 alone, the pentaubiquitin and hexaubiquitin chains were hydrolyzed partially, leaving behind a mixture of monoubiquitin, diubiquitin, triubiquitin and tetraubiquitin. Similarly, OTUD3 incubation resulted in a distinct pattern of bands, with predominantly monoubiquitin, diubiquitin and a weak signal for triubiquitin (Fig. 4b) . 
